Saturday, February 11, 2017 10:10:02 AM
I remember looking at PSTG in the past and didn't get their market cap. They are in a space where there really isn't any barrier to entry and they are losing tons of cash. Market cap was around $4B when I looked at them and it is $2.35B now. Wise to stay away.
A quick look shows they lost $1.76/share last year and the average of 25 analysts shows a .56/share loss this year and .40/share loss for next year. Ummm... they aren't losing money as fast is all I can say for them. I see nothing compelling to do further research, but I plead ignorance. They could be a great prospect, but they aren't my kind of company.
Finjan has zero debt and a durable patent portfolio that pays for the development of two promising business units. Finjan will show a large profit for the year while PSTG has losses forecasted for years into the future which means more debt and dilution in a rising interest rate environment.
No comparison.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM